| Authors: |
Langdahl BL; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: bente.langdahl@aarhus.rm.dk., Silverman S; Cedars-Sinai/UCLA Medical Center and OMC Clinical Research Center, Beverly Hills, CA, USA. Electronic address: stuarts@bhillsra.com., Fujiwara S; Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan., Saag K; Division of Clinical Immunology and Rheumatology, Center for Education and Research on Therapeutics University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: ksaag@uabmc.edu., Napoli N; Division of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy., Soen S; Department of Orthopaedic Surgery and Rheumatology, Kindai University Nara Hospital, Ikoma, Japan. Electronic address: souen@med.kindai.ac.jp., Enomoto H; Eli Lilly Japan K.K., Kobe, Japan. Electronic address: enomoto_hiroyuki@lilly.com., Melby TE; Syneos Health, Raleigh, NC, USA. Electronic address: thomas.melby@syneoshealth.com., Disch DP; Eli Lilly and Company, Indianapolis, IN, USA., Marin F; Lilly Research Centre, Windlesham, UK. Electronic address: marin_fernando@lilly.com., Krege JH; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: krege_john_henry@lilly.com. |
